Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: Effect of ramipril

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 4, 2002, Pages 625-631

  Calò, Lorenzo A ^a   Davis, Paul A ^a   Giacon, Bruno ^a   Pagnin, Elisa ^a   Sartori, Michelangelo ^a   Riegler, Peter ^a   Antonello, Augusto ^a   Huber, Walter ^a   Semplicini, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cyclosporine; Oxidative stress; Posttransplant hypertension; Ramipril; Tacrolimus

Indexed keywords

ANGIOTENSIN; AZATHIOPRINE; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE; DOXAZOSIN; HEME OXYGENASE 1; MESSENGER RNA; RAMIPRIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENDOTHELIUM LESION; ENZYME DEGRADATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCINEURIN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONOCYTES; OXIDATIVE STRESS; RAMIPRIL;

EID: 0036784866     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200210000-00017     Document Type: Article

References (21)

1. First MR, Neylan JF, Rocher LL, et al. Hypertension after renal transplantation. J Am Soc Nephrol 1994;4(suppl):S30-6.
2. Zeier M, Mandelbaum A, Ritz E. Hypertension in the transplanted patient. Nephron 1998;80:257-8.
3. Calò L, Semplicini A, Davis PA, et al. Cyclosporin-induced endothelial disfunction and hypertension: are nitric oxide system abnormality and oxidative stress involved? Transpl Int 2000;13(suppl 1):S413-8.
4. Diederich D, Skopec J, Diederich A, et al. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 1994;23(part 2):957-61.
5. Lopez-Ongil S, Hernandez-Perera O, Navarro-Antolin J, et al. Role of reactive oxygen species in the signaling cascade of cyclosporine A-mediated up-regulation of cNOS in vascular endothelial cells. Br J Pharmacol 1998;124:447-54.
6. Navarro-Antolin J, Hernandez-Perera O, Lopez-Ongil S, et al. CsA and FK506 up regulate cNOS expression: role of reactive oxygen species and AP-1. Kidney Int 1998;suppl 68:S20-4.
7. Remuzzi G, Perico N. Protecting single-kidney allografts from long-term functional deterioration. J Am Soc Nephrol 1998;9:1321-32.
8. Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999;56:783-93.
9. Ader JL, Rostaing L. Cyclosporin nephrotoxicity: patho-physiology and comparison with FK-506. Curr Opin Nephrol Hypertens 1998;7:539-45.
10. Nath KA, Grande J, Croatt A, et al. Redox regulation of renal DNA synthesis, transforming growth factor-beta-1 and collagen gene expression. Kidney Int 1998;53:367-81.
11. Griendling KK, Ushio-Fukai M, Lassegue B, et al. Angiotensin II signaling in vascular smooth muscle: new concepts. Hypertension 1997;29(part 2):366-73.
12. Griendling KK, Sorescu D, Lassègue B, et al. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000;20:2175-83.
13. Basile DP. The transforming growth factor β system in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens 1999;8:21-30.
14. Silacci P, Hayoz D. Oxidative stress as the triggering event for vascular remodeling. Nephrol Dial Transplant 1998;13:1343-6.
15. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997;37:517-54.
16. Skaletsky RS. Primer3. 1998. Code available at: http://www.genome.wi.mit.edu/genome_software/other/primer3.html.
17. Calò L, Ceolotto G, Milani M, et al. Abnormalities of Gq mediated cell signaling in Bartter's and Gitelman's syndromes. Kidney Int 2001;60:882-9.
18. Pagano PJ, Ito Y, Tornheim K, et al. A NADPH superoxide-generating system in the rabbit aorta. Am J Physiol 1995;268:H2264-80.
19. Fukui T, Ishizaka N, Rajagopalan S, et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997;80:45-51.
20. Immenschuh S, Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 2000;60:1121-8.
21. Berkenboom G, Langer I, Carpentier Y, et al. Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins. Hypertension 1997;30(part 1):371-6.